Skip to main content

Scilex Holding Co

SCLXW
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001820190

No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $16.4K in total; no superinvestor holds it.

Other share classesSCLX

Q2 2025 vs. Q1 2025

How the institutions holding Scilex Holding Co changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of SCLXW: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders75−2
Shares244.9K96.9K−148.0K (−60.4%)
Value$39.9K$10.1K−$29.8K (−74.6%)

New holders (1)

Institutions that held Scilex Holding Co at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to SCLXW in Q2 2025
InstitutionSharesValue% of portfolio
Toronto Dominion Bank100$100.00%

Sold out (3)

Institutions that held Scilex Holding Co at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of SCLXW in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Oasis Management Co Ltd.100,000$24.9K
Kelly Financial Services LLC36,000$3.24K
Susquehanna International Group, LLP12,179$1.68K